The in vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer.
Lainé, Anne-Laure
The in vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer. [electronic resource] - Biomaterials Sep 2013 - 6949-56 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1878-5905
10.1016/j.biomaterials.2013.05.065 doi
Animals
Antineoplastic Agents, Hormonal--administration & dosage
Cell Cycle--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Female
Humans
Luminescent Measurements
Mice
Mice, SCID
Molecular Structure
Nanocapsules--chemistry
Tamoxifen--administration & dosage
Triple Negative Breast Neoplasms--drug therapy
The in vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer. [electronic resource] - Biomaterials Sep 2013 - 6949-56 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1878-5905
10.1016/j.biomaterials.2013.05.065 doi
Animals
Antineoplastic Agents, Hormonal--administration & dosage
Cell Cycle--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Female
Humans
Luminescent Measurements
Mice
Mice, SCID
Molecular Structure
Nanocapsules--chemistry
Tamoxifen--administration & dosage
Triple Negative Breast Neoplasms--drug therapy